1. Home
  2. GNLX vs GOODO Comparison

GNLX vs GOODO Comparison

Compare GNLX & GOODO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genelux Corporation

GNLX

Genelux Corporation

SELL

Current Price

$1.91

Market Cap

110.4M

Sector

Health Care

ML Signal

SELL

Logo Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

GOODO

Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

N/A

Current Price

$17.98

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
GNLX
GOODO
Founded
2001
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
110.4M
N/A
IPO Year
2022
2003

Fundamental Metrics

Financial Performance
Metric
GNLX
GOODO
Price
$1.91
$17.98
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $18.83
N/A
AVG Volume (30 Days)
★ 407.6K
6.2K
Earning Date
11-27-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 9.47
N/A
EPS
N/A
★ 0.08
Revenue
$8,000.00
★ $161,336,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$224.63
Revenue Growth
N/A
★ 8.00
52 Week Low
$1.77
$17.49
52 Week High
$5.89
$22.20

Technical Indicators

Market Signals
Indicator
GNLX
GOODO
Relative Strength Index (RSI) 42.60 46.45
Support Level $1.82 $17.50
Resistance Level $2.69 $18.21
Average True Range (ATR) 0.17 0.24
MACD 0.01 0.09
Stochastic Oscillator 34.00 62.95

Price Performance

Historical Comparison
GNLX
GOODO

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

About GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

Share on Social Networks: